Table
From: The effects of dopexamine on renal function in surgical renal artery reconstruction: a pilot study
|  | Pre Drug | Post Ind'n | DPX End Surg. | 24 h post | 2–4 months | re Drug | post Ind'n | PLA End Surg. | 4 h post | 2–4 month |
|---|---|---|---|---|---|---|---|---|---|---|
lox | 74.3± 31.23 |  |  | 62 ± 51.84 |  | 86 ± 29.94 |  |  | 53.6 ± 21.25 |  |
CreaCl |  |  |  | 56.7 ± 38.3 |  |  |  |  | 51.3 ± 21.6 |  |
Creat | 138 ± 63.5 |  |  | 184.2 ± 92.7 | 109.3 ± 23* | 109.4 ± 25.7 |  |  | 174 ± 50.7 | 132.7 ± 9.8 |
% ΔCreat |  |  |  | 30.3 ± 31.4 |  |  |  |  | 66.6 ± 61.5 |  |
UrVol(24) |  |  |  | 2.1 ± 1.03 |  |  |  |  | 3.2 ± 1.05 |  |
pHi |  | 7.39 ± 0.05 | 7.35 ± 0.09 | 7.28 ± 0.14 |  |  | 7.39 ± 0.1 | 7.37 ± 0.04 | 7.29 ± 0.06 |  |
DO21 | 458 ± 87 | 520 ± 93* | 699 ± 163* | 643 ± 224 |  | 512 ± 78 | 412 ± 57 | 516 ± 81 | 552 ± 70 |  |
VO21 | 112 ± 11 | 85 ± 40 | 101 ± 40 | 162 ± 71 |  | 130 ± 23 | 87 ± 7 | 83 ± 21 | 151 ± 26 |  |
O2ER | 24 ± 3 | 16 ± 6 | 14 ± 5 | 26 ± 7 |  | 26 ± 7 | 21 ± 3 | 16 ± 6 | 27 ± 5 |  |